| Financial Year |
March 31 2023 |
| Monetary Funds |
2,137,765,906.48 |
| Held-for-trading Financial Assets |
1,686,570,000.00 |
| Notes Receivable |
5,614,352.61 |
| Accounts Receivable |
219,305,112.58 |
| Advances to Suppliers |
34,092,630.93 |
| Other Receivables |
18,853,454.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
342,734,420.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,235,003.51 |
| Total Current Assets |
4,465,170,881.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
16,869,487.22 |
| Investment Properties |
-- |
| Fixed Assetes |
2,040,899,955.60 |
| Under-construction Projects |
465,620,113.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
8,247,325.00 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
322,086,673.32 |
| R&D expenses |
66,849,326.45 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,751,729.06 |
| Deferred Income Tax Assets |
466,547,964.90 |
| Other Non-Current Assets |
33,410,731.57 |
| Sub-Total of Non-Current Assets |
3,432,456,158.22 |
| Total Assets |
7,897,627,039.38 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
337,827,732.94 |
| Accounts Received In Advance |
6,228,856.87 |
| Employee Compensation Payable |
39,126,284.79 |
| Taxes Payable |
78,294,827.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
109,644,313.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
459,630.34 |
| Other Current Liabilities |
31,389,465.04 |
| Sub-Total of Current Liabilities |
606,684,568.40 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
73,977,223.63 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,657,920.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
106,638,444.55 |
| Total Liabilities |
713,323,012.95 |
| Paid-In Capital(Or Share Stock) |
919,463,954.00 |
| Capital Surplus |
1,994,467,438.25 |
| Surplus Reserve |
486,363,749.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,782,430,829.47 |
| Minority Stockholder's Interest |
2,936,331.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,181,367,694.78 |
| Owner's Equity（Stockholder's Equity） |
7,184,304,026.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,897,627,039.38 |
